Rockefeller Capital Management’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $420K | Buy |
+11,676
| New | +$420K | ﹤0.01% | 1597 |
|
|
2023
Q3 | – | Sell |
-21
| Closed | -$541 | – | 1805 |
|
|
2023
Q2 | $541 | Sell |
21
-26,016
| -100% | -$670K | ﹤0.01% | 1804 |
|
|
2023
Q1 | $391K | Buy |
26,037
+25,000
| +2,411% | +$375K | ﹤0.01% | 1458 |
|
|
2022
Q4 | $12K | Buy |
1,037
+700
| +208% | +$8.1K | ﹤0.01% | 3016 |
|
|
2022
Q3 | $1K | Buy |
337
+21
| +7% | +$62 | ﹤0.01% | 3789 |
|
|
2022
Q2 | $1K | Hold |
316
| – | – | ﹤0.01% | 4018 |
|
|
2022
Q1 | $3K | Sell |
316
-1
| -0.3% | -$9 | ﹤0.01% | 3530 |
|
|
2021
Q4 | $6K | Sell |
317
-1,983
| -86% | -$37.5K | ﹤0.01% | 3217 |
|
|
2021
Q3 | $76K | Sell |
2,300
-45
| -2% | -$1.49K | ﹤0.01% | 1980 |
|
|
2021
Q2 | $90K | Buy |
2,345
+45
| +2% | +$1.73K | ﹤0.01% | 1841 |
|
|
2021
Q1 | $110K | Buy |
2,300
+1,000
| +77% | +$47.8K | ﹤0.01% | 1555 |
|
|
2020
Q4 | $67K | Buy |
1,300
+300
| +30% | +$15.5K | ﹤0.01% | 1583 |
|
|
2020
Q3 | $26K | Buy |
+1,000
| New | +$26K | ﹤0.01% | 1703 |
|